Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 08, 2022

ASTELLAS PHARMA INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 11, 2022

    Zydus Faces Xtandi Cancer Drug Patent Suit

    Astellas Pharma and others have filed a patent infringement suit in New Jersey federal court seeking to block Zydus Pharmaceuticals from launching a generic version of prostate cancer treatment Xtandi, a move that comes amid scrutiny from federal lawmakers over the price of the branded drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login